Avai Bio (AVAI) Interest Expenses (2018 - 2026)

Avai Bio (AVAI) has 9 years of Interest Expenses data on file, last reported at $1.2 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses rose 42.48% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (up 42.48% YoY), and the FY2026 full-year result was $1.2 million, up 42.48% from the prior year.
• Interest Expenses climbed to $1.2 million in Q1 2026, from $864887.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $1.2 million in Q1 2026 to a low of $104128.0 in Q1 2022.
• A 5-year average of $600881.0 and a median of $625043.0 in 2024 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses surged 251.02% in 2024 and jumped 38.37% in 2025, its largest moves.
• Tracing AVAI's Interest Expenses over 5 years: stood at $104128.0 in 2022, then jumped by 71.0% to $178063.0 in 2023, then surged by 251.02% to $625043.0 in 2024, then jumped by 38.37% to $864887.0 in 2025, then jumped by 42.48% to $1.2 million in 2026.
• Business Quant data shows AVAI's Interest Expenses at $1.2 million in Q1 2026, $864887.0 in Q1 2025, and $625043.0 in Q1 2024.